Impact Biomedicines
-
2016
Company Description
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Impact Biomedicines is pioneering the development of life changing treatments for patients with complex cancers. The Company’s pipeline is centered around fedratinib, a potent and highly selective oral small molecule JAK2 kinase inhibitor that is being developed initially for the treatment of myelofibrosis and polycythemia vera.
-
Manufacturer:
Science and Engineering -
Formed:
2016 -
Company Website:
-
Company E-mail:
-
Company Address:
12526 High Bluff Drive, Suite 260San Diego, CAUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits